Clinical Trials Logo

Filter by:
  • Enrolling by invitation  
  • Page [1] ·  Next »
NCT ID: NCT06410612 Enrolling by invitation - Pain, Postoperative Clinical Trials

Block and Periarticular Injection Study

Start date: March 4, 2024
Phase: Phase 4
Study type: Interventional

The purpose of the study is to compare two types of perioperative analgesic modalities, adductor canal block plus interspace between popliteal artery and capsule of the knee (IPACK) block and periarticular injection versus periarticular injection alone, to determine their relative efficacies with regard to pain relief and functional outcomes in the early postoperative period following primary total knee arthroplasty.

NCT ID: NCT06405893 Enrolling by invitation - Healthy Aging Clinical Trials

What Makes People Better at Naming Pictured Objects

Start date: April 4, 2024
Phase: N/A
Study type: Interventional

This study is being conducted to learn more about how mindful breathing might be related to the ability to produce names for pictured objects. Participants will engage with an exercise about mindful breathing or an auditory presentation and then name pictured objects as quickly as they can. They will also complete some surveys and other measures and wearing equipment on their finger to monitor their heart rate throughout the study. Participation will take approximately 1 hour.

NCT ID: NCT06398366 Enrolling by invitation - Cryptogenic Stroke Clinical Trials

Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence

CASPR
Start date: September 14, 2022
Phase:
Study type: Observational

This is a multi-center retrospective analysis of consecutive adult patients with cryptogenic stroke patients following a comprehensive workup for the underlying stroke etiology. Patients will be eligible for inclusion if the index stroke event occurred between 1/1/2016 and 06/30/2022.

NCT ID: NCT06397872 Enrolling by invitation - Renal Impairment Clinical Trials

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses (6 Days) of 100 mg Resmetirom in Subjects With Severe Renal Impairment and in Matched Healthy Control Subjects With Normal Renal Function

Start date: March 5, 2024
Phase: Phase 1
Study type: Interventional

The purpose of this study is to directly characterize the pharmacokinetic (PK) profiles of resmetirom and its major metabolite (MGL-3623) following oral administration of 100 mg resmetirom (QD x 6 days) in subjects with severe renal impairment (RI) compared to healthy matched control subjects with normal renal function.

NCT ID: NCT06397716 Enrolling by invitation - Alcohol Toxicity Clinical Trials

Public Health Initiative on Alcohol Flushing

AIAC
Start date: April 25, 2024
Phase: N/A
Study type: Interventional

The overall aim of the study is to raise awareness of alcohol flushing and its health risks to the general population. The primary objective is to see if spreading awareness of the health risks of alcohol flushing and understanding personalized genotype information will lead to changes in alcohol consumption behavior.

NCT ID: NCT06393634 Enrolling by invitation - Healthy Clinical Trials

Comparing Direct and Indirect Detection Methods of Multiple Routes of Testosterone Administration

T esters
Start date: May 8, 2024
Phase: Early Phase 1
Study type: Interventional

Testosterone abuse is extremely prevalent in athletes globally and especially in the United States professional sporting leagues

NCT ID: NCT06391294 Enrolling by invitation - Epilepsy Clinical Trials

Neuronal and Network Mechanisms of Electrocortical Stimulation

Start date: May 14, 2024
Phase:
Study type: Observational

Electrocortical stimulation (ECS) mapping is a procedure used during brain surgeries, for example when treating diseases like epilepsy or when removing brain tumors. ECS mapping helps surgeons locate areas of the cerebral cortex (the outer part of the brain) that are important for everyday tasks like movement and speech. ECS mapping has been used for decades, and is considered the "gold-standard" tool for locating important areas of cortex. Despite this long history, there is still no clear understanding of exactly how ECS works. The goal of this study is to learn details about the effects ECS has on the brain. The main questions the study aims to answer are: 1) how ECS affects the neurons of the cortex at the stimulation site; and 2) how ECS impacts brain regions that are critically important for human speech and language. These so-called "critical sites" can be physically distant from one another on the brain's surface, requiring extensive ECS mapping and long surgeries. Critical sites are thought to be part of a speech/language network of brain areas, and so the study's goal is to learn about how they are connected. In some participants, the brain's surface will also be slightly cooled. This is a painless procedure that does not harm the brain's function, but could provide insight as to which parts of the brain (the surface, or deeper parts) are responsible for the effects of ECS. By improving the understanding of how ECS affects the brain and improving the ability to identify critical sites, this study could potentially lead to shorter surgeries and better outcomes for future individuals who need this care. Participants will be recruited from among individuals who are undergoing brain surgery for epilepsy treatment or tumor removal. Participants will complete simple tasks like reading words or naming pictures, similar to standard testing that is already performed during their hospital stay.

NCT ID: NCT06389162 Enrolling by invitation - Fatigue Clinical Trials

Dorsolateral Prefrontal Cortex Transcranial Direct Current and Muscle Fatigue Stimulation on Muscle Fatigue

Start date: April 4, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn if transcranial direct current stimulation (tDCS) of the dorsolateral prefrontal cortex (DLPFC) can impact muscle fatigue. The main questions it aims to answer are: 1. Does tDCS of the left DLPFC increase the time that a fatiguing contraction can be maintained? 2. Does tDCS of the left DLPFC decrease the rate of increase of muscle activity, force error, and standard deviation of force during a fatiguing contraction. Researchers will compare tDCS of the left DLPFC to a SHAM stimulation (a type of stimulation that feels like real tDCS but does not elicit physiological effects) to see if tDCS of the left DLPFC works to reduce the progression of muscle fatigue. Participants will: Performing two experimental sessions held 3-10 days apart (usually 7 days) Perform a 9 hole pegboard test, maximum voluntary contractions, and a fatiguing contraction.

NCT ID: NCT06388889 Enrolling by invitation - Eosinophilic Asthma Clinical Trials

Phase III Long-Term Extension Study With Dexpramipexole

EXHALE-5
Start date: May 8, 2024
Phase: Phase 3
Study type: Interventional

The goal of this clinical trial] is to evaluate the long term safety of dexpramipexole treatment in participants with severe asthma, aged ≥12 years, on Global Initiative for Asthma (GINA) 2021 [GINA, 2021] Step 4 or 5 therapy and who completed either of the Phase III studies EXHALE-2 or EXHALE-3.

NCT ID: NCT06388850 Enrolling by invitation - Child Sexual Abuse Clinical Trials

Evaluation of HRP Among Pre-K Through 5th Grade

Start date: March 23, 2023
Phase: N/A
Study type: Interventional

This study is a rigorous experimental evaluation of an existing manualized universal child sexual abuse primary prevention program with a history of 30+ years of implementation across 30 states and robust pilot data.